Status:

NOT_YET_RECRUITING

Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

Acute-on-Chronic Liver Failure (ACLF)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Acute-on-chronic liver failure (ACLF) is a serious condition in which patients with chronic liver disease suddenly develop severe liver injury, leading to inflammation, organ failure, and very high sh...

Detailed Description

Acute-on-chronic liver failure (ACLF) is characterized by acute deterioration of liver function in patients with chronic liver disease, leading to systemic inflammation, organ failure, and high short-...

Eligibility Criteria

Inclusion

  • ACLF patients of any etiology with systemic inflammatory response syndrome and AARC grade II or more.

Exclusion

  • Patients eligible for corticosteroids for severe alcohol-associated hepatitis related ACLF (other than hydrocortisone according to Surviving Sepsis Campaign Guidelines 2021 which is 50 mg iv q 6 h for management of refractory shock
  • Hepatocellular carcinoma or any extrahepatic malignancy,
  • Active fungal sepsis
  • Disseminated intravascular coagulation
  • Hemodynamic instability requiring norepinephrine \>0.20ug/kg/min
  • Patients with coma of non-hepatic origin
  • Patients with PaO2/FiO2 ratio \<150
  • Pregnancy
  • Comorbidities associated with poor outcomes (severe cardiopulmonary disease defined by a New York Heart Association score \>3, or oxygen/steroid-dependent chronic obstructive pulmonary disease, chronic kidney disease) and patients with post-resection liver failure
  • Patients with fibrinogen \<110 and/or platelets less than 50,000
  • Patients with oliguria with urine output less than 400 ml/day
  • Lack of informed consent
  • Patient enrolled in other clinical trials

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2027

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT07178366

Start Date

October 1 2025

End Date

October 1 2027

Last Update

September 24 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial) | DecenTrialz